INVASIVE PNEUMOCOCCAL DISEASE IN PATIENTS FROMA PEDIATRIC HOSPITAL IN PERU, 2017-2020

被引:0
作者
Marin-Portocarrero, Julio Guillermo [1 ,2 ]
Quispe-Sanchez, Alan [1 ]
Charca-Rodriguez, Flor de Maria [1 ]
Atamari-Anahui, Noe [1 ,3 ]
机构
[1] Inst Nacl Salud Nino Brena, Lima, Peru
[2] Univ Nacl Federico Villarreal, Fac Human Med, Lima, Peru
[3] Univ San Ignacio Loyola, Res Unit Hlth Evidence Generat & Synth, Vicerrectorado Invest, Lima, Peru
来源
REVISTA PERUANA DE MEDICINA EXPERIMENTAL Y SALUD PUBLICA | 2022年 / 39卷 / 04期
关键词
Streptococcus pneumoniae; Pneumococcal Vaccines; Child; Peru (Source: MeSH NLM); STREPTOCOCCUS-PNEUMONIAE; CHILDREN;
D O I
10.17844/rpmesp.2022.394.12054
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This study aimed to describe the clinical characteristics, serotypes, and antibiotic susceptibility in patients with invasive pneumococcal disease (IPD). The medical records of patients with IPD who were hospitalized at the Instituto Nacional de Salud del Ni & ntilde;o-Bre & ntilde;a (Lima, Peru) were reviewed. We evaluated 29 patients. The median age was 1.9 years (interquartile range: 1 to 4 years). Of the sample, 51.7% were women and the most frequent clinical form of IPD was bacteremia in 18 (62.1%) patients; 65.5% had a complete vaccination schedule, according to the Peruvian Ministry of Health. Germ isolation was performed from blood samples in 82.8% of patients. Antibiotic resistance to erythromycin (55.2%) was the most frequent, followed by resistance to trimethoprim-sulfamethoxazole (48.3%) and penicillin (24.1%). The isolated serotypes were 6C, 19A, 23A and 24F. One patient died of meningitis. In conclusion, IPD was more frequent in children aged one to five years and the most frequent clinical form was bacteremia. Five serotypes reported in previous studies were found to be resistant to penicillin and erythromycin.
引用
收藏
页数:6
相关论文
共 50 条
[31]   Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7-Valent Pneumococcal Conjugate Vaccine Introduction, 1997-2007 [J].
Ardanuy, Carmen ;
Tubau, Fe ;
Pallares, Roman ;
Calatayud, Laura ;
Angeles Dominguez, Maria ;
Rolo, Dora ;
Grau, Inmaculada ;
Martin, Rogelio ;
Linares, Josefina .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :57-64
[32]   Airway Anomalies in Pediatric Patients After Surgery for Congenital Heart Disease: Single-Center Retrospective Cohort Study, Taiwan, 2017-2020 [J].
Wu, Jeng-Hung ;
Wu, En-Ting ;
Chou, Heng-Wen ;
Wang, Ching-Chia ;
Lu, Frank Leigh ;
Wang, Yi-Chia ;
Huang, Chi-Hisang ;
Chen, Shyh-Jye ;
Chen, Yih-Sharng ;
Huang, Shu-Chien .
PEDIATRIC CRITICAL CARE MEDICINE, 2024, 25 (11) :e438-e446
[33]   Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units [J].
Diaz-Conradi, Alvaro ;
Jose Garcia-Garcia, Juan ;
Gonzalez Peris, Sebastia ;
Fernandez de Sevilla, Mariona ;
Moraga Llop, Fernando ;
Sol Ventura, Paula ;
Dominguez, Angela .
ANALES DE PEDIATRIA, 2021, 94 (01) :19-27
[34]   Serotype distribution, clinical characteristics, and antimicrobial resistance of pediatric invasive pneumococcal disease in Colombia during PCV10 mass vaccination (2017-2022) [J].
Camacho-Moreno, German ;
Leal, Aura Lucia ;
Patino-Nino, Jaime ;
Vasquez-Hoyos, Pablo ;
Gutierrez, Ivan ;
Beltran, Sandra ;
Alvarez-Olmos, Martha I. ;
Marino, Ana-Cristina ;
Londono-Ruiz, Juan Pablo ;
Barrero, Rocio ;
Rojas, Juan Pablo ;
Espinosa, Fabio ;
Arango-Ferreira, Catalina ;
Suarez, Maria Alejandra ;
Trujillo, Monica ;
Lopez-Medina, Eduardo ;
Lopez, Pio ;
Coronell, Wilfrido ;
Ramos, Nicolas ;
Restrepo, Alejandro ;
Montanez, Anita ;
Moreno, Vivian Marcela .
FRONTIERS IN MEDICINE, 2024, 11
[35]   Pediatric Invasive Pneumococcal Disease in Taiwan Following a National Catch-up Program With the 13-Valent Pneumococcal Conjugate Vaccine [J].
Wei, Sung-Hsi ;
Chiang, Chuen-Sheue ;
Chiu, Cheng-Hsun ;
Chou, Pesus ;
Lin, Tzou-Yien .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (03) :E71-E77
[36]   Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines [J].
Dion, Stephane B. ;
Major, Maria ;
Grajales, Ana Gabriela ;
Nepal, Rajeev M. ;
Cane, Alejandro ;
Gessner, Bradford ;
Vojicic, Jelena ;
Suaya, Jose A. .
VACCINE, 2021, 39 (22) :3007-3017
[37]   Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020 [J].
Link-Gelles, Ruth ;
Taylor, Thomas ;
Moore, Matthew R. .
VACCINE, 2013, 31 (22) :2572-2577
[38]   Management of invasive pneumococcal disease in HIV-infected patients [J].
Munier, A. -L. ;
de Lastours, V. ;
Molina, J. -M. .
JOURNAL DES ANTI-INFECTIEUX, 2012, 14 (03) :127-135
[39]   Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru [J].
Ochoa, Theresa J. ;
Del Aguila, Olguita ;
Reyes, Isabel ;
Chaparro, Eduardo ;
Campos, Francisco ;
Saenz, Andres ;
Hernandez, Roger ;
Luna-Muschi, Alessandra ;
Castillo-Tokumori, Franco ;
Montero, Andrea E. ;
Gonzales, Brayan E. ;
Mercado, Erik H. .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (01) :44-50
[40]   Changes in the Features of Invasive Pneumococcal Disease after Introduction of the Seven-valent Pneumococcal Conjugate Vaccine in a Regional Core Hospital of Kochi, Japan [J].
Miyahara, Hiroyuki ;
Maruyama, Hidehiko ;
Kanazawa, Akane ;
Iwasaki, Yuka ;
Shigemitsu, Yusuke ;
Watanabe, Hirokazu ;
Tokorodani, Chiho ;
Miyazawa, Mari ;
Nakata, Yusei ;
Nishiuchi, Ritsuo ;
Kikkawa, Kiyoshi .
ACTA MEDICA OKAYAMA, 2015, 69 (04) :255-260